November 3, 2014

A potentially breathable, respiratory vaccine in development has been shown to provide long-term protection for nonhuman primates against the Ebola virus.

 

October 31, 2014

The response to the current global Ebola scare from both the pharmaceutical and pharmacy industries has been nothing short of remarkable. Precautionary preparations have been made to address the Ebola concerns in the United States; several pharmaceutical manufacturers have been working around the clock toward an Ebola vaccine and treatment; and there has been an outpooring of goods that have been directed to help with the outbreak in West Africa. 

Ebola is not a problem in the United States, at least not yet (nor hopefully will it ever be), but the pharmaceutical community is stepping up to help around the world. And in the U.S., there is much being done to help the pharmacy world prepare.

 

October 31, 2014

As many as 62% of attendees at the Academy of Integrative Health & Medicine annual conference this week said that the most important factor in stopping Ebola in the United States is controlling the virus and caring for afflicted patients in West Africa.

October 28, 2014

The Retail Orphan Initiative on Tuesday hosted a webinar detailing a major charitable campaign to fight Ebola in Liberia.

October 27, 2014

Responding to the Ebola virus epidemic, the Retail Orphan Initiative on Monday announced a major campaign to help fight Ebola in Liberia. 

October 27, 2014

Rx Response moved to alert status in response to the concern about Ebola in the United States.

October 22, 2014

The pharmaceutical industry has committed considerable resources to developing both vaccines and treatments to address the current Ebola crisis.

 

October 16, 2014
AdAge on Thursday attributed higher sales of hand sanitizer and disinfectants to the rise in Ebola-related media reports.
October 14, 2014

Cardinal Health on Tuesday announced it had recently donated more than 1 million products to AmeriCares Emergency Response Program to help contain the deadly Ebola outbreak in West Africa. 

October 9, 2014

At a time when nearly every media outlet is covering Ebola, Enterovirus D-68, or a new outbreak of an infectious disease, the American Pharmacists Association is reminding Americans that the nation’s pharmacists are ready to help.

October 8, 2014

The dietary supplement industry on Tuesday spoke out against any supplement manufacturer making advertising claims around the Ebola virus.

October 7, 2014

Biopharmaceutical company Chimerix on Monday announced that brincidofovir has been provided for potential use in patients with Ebola virus at the request of treating physicians.

October 3, 2014

Biolife is helping to combat the Ebola issue with the donation of its WoundSeal product, which helps stop bleeding and seals wounds, to Africa, according to a report from ABC affiliate WWSB

 

September 18, 2014

McKesson donated four million pairs of latex gloves to World Vision, the wholesaler announced Thursday.

August 21, 2014

Hospitals and state laboratories in the United States have processed more than 60 Ebola scares over the course of the last few weeks, according to a report from ABC News.

 

August 7, 2014

A new experimental drug to treat Ebola has been tried in the two American patients being treated in an Atlanta hospital, The New York Times reported Wednesday

August 5, 2014

New York City's Department of Health and Mental Hygiene said a man who was tested for Ebola at Mount Sinai Hospital is "unlikely" to have the virus. The patient was admitted to the hospital early Monday with a fever and gastrointestinal problems. He recently visited a West African country where Ebola was reported, according to the Washington Post.

March 20, 2014

The Food and Drug Administration announced the approval of Impavido (miltefosine) to treat a tropical disease called leishmaniasis. Leishmaniasis is caused by Leishmania, a parasite transmitted to humans through sand fly bites.

January 20, 2014

Bayer's Advantage Multi for Dogs (imidacloprid + moxidectin) received Food and Drug Administration approval as the first-ever treatment for circulating microfilaria in heartworm-positive dogs.

April 29, 2013

The risk of Lyme disease in dogs will be "extremely high" this year, an expert group has warned.

April 19, 2013

A veterinary group in Texas is urging pet owners to protect their cats and dogs from heartworms.

December 17, 2012

The Food and Drug Administration has approved a new biotech drug from GlaxoSmithKline for anthrax, the drug maker said.

March 9, 2012

A company that makes pet drugs has launched what it calls the first generic prescription heartworm preventive medication for sale at retail pharmacies around the country.

November 9, 2011

According to the most recent consumer snapshot survey by Interclick, 42% of Americans are planning to be immunized this year.